185 related articles for article (PubMed ID: 26640145)
1. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
2. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
[TBL] [Abstract][Full Text] [Related]
3. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
Chakravarti N; Boles A; Burzinski R; Sindaco P; Isabelle C; McConnell K; Mishra A; Porcu P
Sci Rep; 2024 Apr; 14(1):9305. PubMed ID: 38653804
[TBL] [Abstract][Full Text] [Related]
4. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
[TBL] [Abstract][Full Text] [Related]
5. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.
Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
7. Integrative data modeling from lung and lymphatic cancer predicts functional roles for miR-34a and miR-16 in cell fate regulation.
Gupta S; Silveira DA; Barbé-Tuana FM; Mombach JCM
Sci Rep; 2020 Feb; 10(1):2511. PubMed ID: 32054948
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
Afanasyeva EA; Mestdagh P; Kumps C; Vandesompele J; Ehemann V; Theissen J; Fischer M; Zapatka M; Brors B; Savelyeva L; Sagulenko V; Speleman F; Schwab M; Westermann F
Cell Death Differ; 2011 Jun; 18(6):974-84. PubMed ID: 21233845
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.
Kuttikrishnan S; Masoodi T; Ahmad F; Sher G; Prabhu KS; Mateo JM; Buddenkotte J; El-Elimat T; Oberlies NH; Pearce CJ; Bhat AA; Alali FQ; Steinhoff M; Uddin S
J Dermatol Sci; 2023 Nov; 112(2):83-91. PubMed ID: 37865581
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Histone H3.3 Induces p53-Dependent Cellular Senescence in Human Diploid Fibroblasts.
Yamamoto Y; Takahashi RU; Kinehara M; Yano K; Kuramoto T; Shimamoto A; Tahara H
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790171
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
Wang C; Chen Z; Ge Q; Hu J; Li F; Hu J; Xu H; Ye Z; Li LC
FEBS Lett; 2014 Dec; 588(24):4654-64. PubMed ID: 25447520
[TBL] [Abstract][Full Text] [Related]
12. BRD4 regulates cellular senescence in gastric cancer cells via E2F/miR-106b/p21 axis.
Dong X; Hu X; Chen J; Hu D; Chen LF
Cell Death Dis; 2018 Feb; 9(2):203. PubMed ID: 29434197
[TBL] [Abstract][Full Text] [Related]
13. CD95 is part of a let-7/p53/miR-34 regulatory network.
Hau A; Ceppi P; Peter ME
PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
[TBL] [Abstract][Full Text] [Related]
14. Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
Lee M; Kistler C; Hartmann TB; Li F; Dummer R; Dippel E; Booken N; Klemke CD; Schadendorf D; Eichmüller SB
Cancer Immunol Immunother; 2007 Jun; 56(6):783-95. PubMed ID: 17089123
[TBL] [Abstract][Full Text] [Related]
15. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.
Park J; Daniels J; Wartewig T; Ringbloom KG; Martinez-Escala ME; Choi S; Thomas JJ; Doukas PG; Yang J; Snowden C; Law C; Lee Y; Lee K; Zhang Y; Conran C; Tegtmeyer K; Mo SH; Pease DR; Jothishankar B; Kwok PY; Abdulla FR; Pro B; Louissaint A; Boggon TJ; Sosman J; Guitart J; Rao D; Ruland J; Choi J
Blood; 2021 Oct; 138(14):1225-1236. PubMed ID: 34115827
[TBL] [Abstract][Full Text] [Related]
18. Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis.
Abdulrahman N; Leo R; Boumenar HA; Ahmad F; Mateo JM; Jochebeth A; Al-Sowaidi NK; Sher G; Ansari AW; Alam M; Uddin S; Ahmad A; Steinhoff M; Buddenkotte J
Leuk Lymphoma; 2023 Dec; 64(14):2236-2248. PubMed ID: 37708450
[TBL] [Abstract][Full Text] [Related]
19. New
Velatooru LR; Hu CH; Bijani P; Wang X; Bojaxhi P; Chen H; Duvic M; Ni X
Cells; 2023 Sep; 12(19):. PubMed ID: 37830594
[TBL] [Abstract][Full Text] [Related]
20. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
